| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.7 | 1-year : | 5.49 |
| Resists | First : | 4.03 | Second : | 4.7 |
| Pivot price | 3.33  |
|||
| Supports | First : | 3.03 | Second : | 2.42 |
| MAs | MA(5) : | 3.79 |
MA(20) : | 3.21 |
| MA(100) : | 2.49 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 79 |
D(3) : | 79.9 |
| RSI | RSI(14): 65.4 |
|||
| 52-week | High : | 4.03 | Low : | 0.68 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ESPR ] has closed below upper band by 24.9%. Bollinger Bands are 142.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.91 - 3.93 | 3.93 - 3.95 |
| Low: | 3.72 - 3.74 | 3.74 - 3.76 |
| Close: | 3.76 - 3.79 | 3.79 - 3.82 |
Fri, 05 Dec 2025
Two Seas Capital LP Raises Holdings in Esperion Therapeutics, Inc. $ESPR - MarketBeat
Thu, 04 Dec 2025
What momentum indicators show for ESPR stock - Trade Risk Assessment & AI Based Trade Execution Alerts - Newser
Tue, 25 Nov 2025
Piper Sandler Initiates Coverage of Esperion Therapeutics (ESPR) with Overweight Recommendation - Nasdaq
Tue, 25 Nov 2025
New Analyst Forecast: $ESPR Given $9.0 Price Target - Quiver Quantitative
Tue, 25 Nov 2025
$ESPR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative
Wed, 19 Nov 2025
Esperion (NASDAQ: ESPR) to Present at Piper Sandler 37th Annual Healthcare Conference - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 237 (M) |
| Shares Float | 235 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 47.2 (%) |
| Shares Short | 24,960 (K) |
| Shares Short P.Month | 24,420 (K) |
| EPS | -0.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.21 |
| Profit Margin | -34.9 % |
| Operating Margin | -11.5 % |
| Return on Assets (ttm) | -5.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 69 % |
| Gross Profit (p.s.) | 0.55 |
| Sales Per Share | 1.28 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -93 (M) |
| Levered Free Cash Flow | -78 (M) |
| PE Ratio | -7.02 |
| PEG Ratio | 0 |
| Price to Book value | -1.73 |
| Price to Sales | 2.95 |
| Price to Cash Flow | -9.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|